ADMA Biologics Inc
ADMABiotechnology
$11.75+4.17%As of Oct 29vs prior close
- Market cap
- $2.6B
- P/E (TTM)
- 15.6×
- From 52W high
- −42.35%
- EPS (LTM)
- $0.70
- Revenue (LTM)
- $512.3M
- Net margin
- 32.98%
- Dividend yield
- 0.00%
Nomior Score
56
Anchored CompounderTop 35% of the scored universe
Growth62
Quality80
Value59
Momentum21
Resilience50
Growth
+53.69%revenue a year over 9 fiscal years
YE16 $10.7MLTM $512.3M
Connections
Revenue to profitQ2 YE26
30% of revenue became net profit, up 2 pts on a year.
Who owns it
2funds, 2 tracked portfolios